Alpheus Medical Secures $52 Million to Propel Innovative Therapy for Glioblastoma Treatment Alpheus Medical has successfully raised $52 million in funding to further develop its sonodynamic therapy for glioblastoma, enhancing treatment options for patients.

Alpheus Medical Secures $52 Million to Propel Innovative Therapy for Glioblastoma Treatment #United_States #Alpheus_Medical #Sonodynamic_Therapy #Chanhassen #Glioblastoma

Alpheus Medical's Groundbreaking Sonodynamic Therapy Shows Promise for Glioblastoma Treatment Alpheus Medical has revealed encouraging results from its sonodynamic therapy for glioblastoma, indicating potential for significant cancer treatment advancements in newly diagnosed patients.

Alpheus Medical's Groundbreaking Sonodynamic Therapy Shows Promise for Glioblastoma Treatment #USA #Alpheus_Medical #Sonodynamic_Therapy #Chanhassen #Glioblastoma

Alpheus Medical's Breakthrough Therapy Shows Promising Results for High-Grade Gliomas Alpheus Medical, Inc. reports significant Phase 1/2 trial results revealing that its innovative therapy doubles survival rates for high-grade glioma patients.

Alpheus Medical's Breakthrough Therapy Shows Promising Results for High-Grade Gliomas #United_States #Alpheus_Medical #Sonodynamic_Therapy #Gliomas #Chanhassen